Moncef Mohamed Slaoui
(; ; ary, منصف السلاوي, ; born July 22, 1959) is a
Moroccan
Moroccan may refer to:
* Something or someone from, or related to the country of Morocco
* Moroccan people
* Moroccan Arabic, spoken in Morocco
* Moroccan Jews
See also
* Morocco leather
Morocco leather (also known as Levant, the French Maro ...
-born
Belgian
Belgian may refer to:
* Something of, or related to, Belgium
* Belgians, people from Belgium or of Belgian descent
* Languages of Belgium, languages spoken in Belgium, such as Dutch, French, and German
*Ancient Belgian language, an extinct language ...
-
American researcher who served as the head of
Operation Warp Speed
Operation Warp Speed (OWS) was a public–private partnership initiated by the United States government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. The firs ...
(OPWASP) under President
Donald Trump
Donald John Trump (born June 14, 1946) is an American politician, media personality, and businessman who served as the 45th president of the United States from 2017 to 2021.
Trump graduated from the Wharton School of the University of ...
from 2020 to 2021.
Slaoui is the former head of the vaccines department at
GlaxoSmithKline
GSK plc, formerly GlaxoSmithKline plc, is a British Multinational corporation, multinational pharmaceutical and biotechnology company with global headquarters in London, England. Established in 2000 by a Mergers and acquisitions, merger of Gl ...
(GSK).
[ ] He worked at the company for thirty years, retiring in 2017. On May 15, 2020, President
Donald Trump
Donald John Trump (born June 14, 1946) is an American politician, media personality, and businessman who served as the 45th president of the United States from 2017 to 2021.
Trump graduated from the Wharton School of the University of ...
announced that Slaoui would manage the U.S. government's development of a vaccine used to treat
coronavirus disease
Coronavirus diseases are caused by viruses in the coronavirus subfamily, a group of related RNA viruses that cause diseases in mammals and birds. In humans and birds, the group of viruses cause respiratory tract infections that can range fro ...
in OPWASP;
Slaoui resigned on January 12, 2021 after successfully having helped introduce a number of vaccines to the US and global markets. In March 2021, he was fired from the board of GSK subsidiary, Galvani Bioelectronics, over what GSK called “substantiated” sexual harassment allegations stemming from his time at the parent company.
Early life and education
Slaoui was born on July 22, 1959, in
Agadir
Agadir ( ar, أݣادير, ʾagādīr; shi, ⴰⴳⴰⴷⵉⵔ) is a major city in Morocco, on the shore of the Atlantic Ocean near the foot of the Atlas Mountains, just north of the point where the Souss River flows into the ocean, and south ...
,
Morocco
Morocco (),, ) officially the Kingdom of Morocco, is the westernmost country in the Maghreb region of North Africa. It overlooks the Mediterranean Sea to the north and the Atlantic Ocean to the west, and has land borders with Algeria ...
.
The city was evacuated in February 1960 after an
earthquake
An earthquake (also known as a quake, tremor or temblor) is the shaking of the surface of the Earth resulting from a sudden release of energy in the Earth's lithosphere that creates seismic waves. Earthquakes can range in intensity, from ...
, and Slaoui was raised in
Casablanca.
[ His father worked in the irrigation business] and died when Slaoui was a teenager, leaving his mother to raise him and his four siblings.
Slaoui graduated from Mohammed V High School in Casablanca. In 1976 at age 17, Slaoui left Morocco to study medicine in France but missed the registration deadline due to new registration procedures and his mother being ill. He enrolled at the Université libre de Bruxelles, where he received a BS and MS in biology. During this time he was very politically active. In 1983, Slaoui earned a PhD PHD or PhD may refer to:
* Doctor of Philosophy (PhD), an academic qualification
Entertainment
* '' PhD: Phantasy Degree'', a Korean comic series
* ''Piled Higher and Deeper
''Piled Higher and Deeper'' (also known as ''PhD Comics''), is a newsp ...
in molecular biology
Molecular biology is the branch of biology that seeks to understand the molecular basis of biological activity in and between cells, including biomolecular synthesis, modification, mechanisms, and interactions. The study of chemical and phys ...
and immunology
Immunology is a branch of medicineImmunology for Medical Students, Roderick Nairn, Matthew Helbert, Mosby, 2007 and biology that covers the medical study of immune systems in humans, animals, plants and sapient species. In such we can see ther ...
from the Free University of Brussels. His thesis was titled
Etude de la diversité et de la sélection des répertoires idiotypiques dans le système immunitaire
'. Slaoui's doctoral advisor
A doctoral advisor (also dissertation director, dissertation advisor; or doctoral supervisor) is a member of a university faculty whose role is to guide graduate students who are candidates for a doctorate, helping them select coursework, as well ...
was immunologist Jacques Urbain
Jacques Urbain is a Belgian scientist, and professor at the Université libre de Bruxelles. In 1987, he was awarded the Francqui Prize on Biological and Medical Sciences for his work on immunology
Immunology is a branch of medicineImmunol ...
.
Slaoui took postgraduate courses at Harvard Medical School
Harvard Medical School (HMS) is the graduate medical school of Harvard University and is located in the Longwood Medical and Academic Area, Longwood Medical Area of Boston, Massachusetts. Founded in 1782, HMS is one of the oldest medical schools ...
and the Tufts University School of Medicine
The Tufts University School of Medicine is the medical school of Tufts University, a private research university in Massachusetts. It was established in 1893 and is located on the university's health sciences campus in downtown Boston.
The ''T ...
without earning degrees. In 1998, he received an accelerated MBA
A Master of Business Administration (MBA; also Master's in Business Administration) is a postgraduate degree focused on business administration. The core courses in an MBA program cover various areas of business administration such as accoun ...
from the International Institute for Management Development
International Institute for Management Development (IMD) is a private business school in Lausanne, Switzerland specializes in executive education offering open enrollment programs for senior executives, as well as longer-term educational engage ...
(IMD) in Lausanne
Lausanne ( , , , ) ; it, Losanna; rm, Losanna. is the capital and largest city of the Swiss French speaking canton of Vaud. It is a hilly city situated on the shores of Lake Geneva, about halfway between the Jura Mountains and the Alps, and fac ...
, Switzerland.[
]
Career
Slaoui and his wife lived in the United States from 1983 to 1985 while each did post-doctoral research at Harvard. When she was recruited to continue research on influenza at SmithKline-RIT in Belgium (which would later become part of GlaxoSmithKline
GSK plc, formerly GlaxoSmithKline plc, is a British Multinational corporation, multinational pharmaceutical and biotechnology company with global headquarters in London, England. Established in 2000 by a Mergers and acquisitions, merger of Gl ...
(GSK)), Slaoui got a job teaching immunology at the University of Mons
The University of Mons (french: Université de Mons) is a Belgian university located in the city of Mons, founded in 2009 by merging the Engineering Faculty of Mons (FPMs) and the University of Mons-Hainaut. The merging of the institutions was ...
in Belgium
Belgium, ; french: Belgique ; german: Belgien officially the Kingdom of Belgium, is a country in Northwestern Europe. The country is bordered by the Netherlands to the north, Germany to the east, Luxembourg to the southeast, France to ...
.
Slaoui has co-authored more than 100 research papers.[
]
GlaxoSmithKline
In 1988, after consulting for SmithKline-RIT for three years, Slaoui joined the company as a vaccine researcher.[ In 2006, he was appointed head of research and development at GlaxoSmithKline, succeeding ]Tachi Yamada
Tadataka "Tachi" Yamada KBE (山田忠孝 Yamada Tadataka or "ターチ Tachi"; 5 June 1945 – 4 August 2021) was a Japanese-born American physician and gastroenterologist. He was a venture partner of Frazier Healthcare Partners.
Early life ...
. In 2007, he announced plans to establish a neurosciences research group in Shanghai
Shanghai (; , , Standard Mandarin pronunciation: ) is one of the four direct-administered municipalities of the People's Republic of China (PRC). The city is located on the southern estuary of the Yangtze River, with the Huangpu River flowin ...
that would employ a thousand scientists and cost $100 million; it ceased operations in August 2017.
In 2008, Slaoui led the $720 million acquisition of Sirtris Pharmaceuticals
Sirtris Pharmaceuticals, Inc. was a biotechnology company based in Cambridge, MA that developed therapies for type 2 diabetes, cancer, and other diseases. Conceived in 2004 by Harvard University biologist David Sinclair and serial entrepreneur And ...
, which folded amidst turmoil in 2013.[ In 2012, he oversaw GSK's purchase of ]Human Genome Sciences
Human Genome Sciences (HGS) was a biopharmaceutical corporation founded in 1992 by Craig Venter, Alan Walton and Wally Steinberg. It uses the human DNA sequence to develop protein and antibody drugs. It had drugs under development to treat suc ...
for over $3 billion. He "sold off GSK’s entire oncology
Oncology is a branch of medicine that deals with the study, treatment, diagnosis and prevention of cancer. A medical professional who practices oncology is an ''oncologist''. The name's etymological origin is the Greek word ὄγκος (''ó ...
business, which Novartis
Novartis AG is a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and
Cambridge, Massachusetts, United States (global research).name="novartis.com">https://www.novartis.com/research-development/research-loc ...
turned into a 'cancer heavyweight'" One "pharma industry veteran" told a reporter in 2020 that "those are three of the worst deals in drug industry history."[
Slaoui spent thirty years working at GSK.][ During his time there, Slaoui oversaw the development of numerous vaccines, including ]Cervarix
Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV).
Cervarix is designed to prevent infection from HPV types 16 and 18, that cause about 70% of cervical cancer cases. These types also cause most HPV-induced ...
to prevent cervical cancer
Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Early on, typically no symptoms are seen. Later symptoms may include abnormal ...
, Rotarix to prevent gastroenteritis
Gastroenteritis, also known as infectious diarrhea and gastro, is an inflammation of the gastrointestinal tract including the stomach and intestine. Symptoms may include diarrhea, vomiting, and abdominal pain. Fever, lack of energy, and dehydrat ...
in children, and an Ebola
Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a viral hemorrhagic fever in humans and other primates, caused by ebolaviruses. Symptoms typically start anywhere between two days and three weeks after bec ...
vaccine.[ He also spent 27 years researching on a ]malaria vaccine
A malaria vaccine is a vaccine that is used to prevent malaria. The only approved use of a vaccine outside the EU, as of 2022, is RTS,S, known by the brand name ''Mosquirix''. In October 2021, the WHO for the first time recommended the large-sc ...
, Mosquirix, that was approved by the European Medicines Agency in 2015 and touted as the first in the world.
In April 2013, he co-wrote a paper with several other GSK heads that introduced the term " electroceutical" to broadly encompass medical devices
A medical device is any device intended to be used for medical purposes. Significant potential for hazards are inherent when using a device for medical purposes and thus medical devices must be proved safe and effective with reasonable assur ...
that use electrical, mechanical, or light stimulation to affect electrical signaling in relevant tissue types.[ ] Over the next several years, he attempted to sell a public audience on GSK's development of bioelectronic medicine, with appearances on YouTube
YouTube is a global online video sharing and social media platform headquartered in San Bruno, California. It was launched on February 14, 2005, by Steve Chen, Chad Hurley, and Jawed Karim. It is owned by Google, and is the second most ...
and at futurist conferences.
In July 2013, he wrote an op-ed
An op-ed, short for "opposite the editorial page", is a written prose piece, typically published by a North-American newspaper or magazine, which expresses the opinion of an author usually not affiliated with the publication's editorial board. ...
in the '' Huffington Post'' entitled "It’s Time to Further Incentivize Medical Innovation", in which he outlined three recommendations to improve the effectiveness of the pharmaceutical industry.
The Slaoui Center for Vaccines Research in Rockville, Maryland
Maryland ( ) is a U.S. state, state in the Mid-Atlantic (United States), Mid-Atlantic region of the United States. It shares borders with Virginia, West Virginia, and the District of Columbia to its south and west; Pennsylvania to its north; ...
—named after Slaoui and GSK's first research and development
Research and development (R&D or R+D), known in Europe as research and technological development (RTD), is the set of innovative activities undertaken by corporations or governments in developing new services or products, and improving existi ...
institute in the United States—was opened on December 14, 2016.
As of 2016, Slaoui was on the board of directors of the PhRMA
Pharmaceutical Research and Manufacturers of America (PhRMA, pronounced ), formerly known as the Pharmaceutical Manufacturers Association, is a trade group representing companies in the pharmaceutical industry in the United States. Founded in 195 ...
lobby.
In 2016 he was named to the inaugural board of directors of Galvani Bioelectronics
Galvani Bioelectronics is a Stevenage, United Kingdom-based bioelectronics R&D company.
History
It was founded by Alphabet Inc. subsidiary Verily Life Sciences and British pharmaceutical company GlaxoSmithKline (GSK) in November 2016. The partn ...
, the joint venture between GSK and Alphabet Corporation subsidiary Verily Life Sciences
Verily Life Sciences, also known as Verily (formerly Google Life Sciences), is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until August 10, 2015, when Serge ...
.
Slaoui retired from GSK on June 30, 2017.
Corporate directorships
In July 2017, he joined Moderna
Moderna, Inc. ( ) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to pro ...
's Board of Directors.
In September 2017, he joined European venture capital firm Medicxi.
COVID-19 pandemic and OPWASP
On May 15, 2020, President Donald Trump
Donald John Trump (born June 14, 1946) is an American politician, media personality, and businessman who served as the 45th president of the United States from 2017 to 2021.
Trump graduated from the Wharton School of the University of ...
officially announced OPWASP, a project to develop and deliver 300 million doses of a vaccine for the coronavirus disease 2019
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by a virus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known case was identified in Wuhan, China, in December 2019. The disease quickly ...
by January 2021. Slaoui was named to lead the project, working alongside chief operating officer and four-star general Gustave F. Perna. Other candidates for Slaoui's position reportedly included Elias Zerhouni
Elias Zerhouni (in Arabic إلياس زرهوني) (born April 12, 1951) is an Algerian-born American scientist, radiologist and biomedical engineer.
He spent much of his career on the faculty of the Johns Hopkins University School of Medicine ...
and Arthur Levinson
Arthur D. Levinson (born March 31, 1950) is an American businessman and is the current chairman of Apple Inc. (2011–present) and CEO of Calico (an Alphabet Inc. venture). He is the former chief executive officer (1995–2009) and chairman (199 ...
.[ President Trump described Slaoui as "one of the most respected men in the world in the production and, really, on the formulation of vaccines", while Secretary of Health and Human Services ]Alex Azar
Alex Michael Azar II (; born June 17, 1967) is an American attorney, businessman, lobbyist, and former pharmaceutical executive who served as the United States secretary of health and human services from 2018 to 2021. Azar was nominated to his ...
praised him as "arguably the world’s most experienced and successful vaccine developer".
To avoid a conflict of interest, Slaoui resigned from the board of the Massachusetts-based biotech firm Moderna
Moderna, Inc. ( ) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to pro ...
, which had been developing a vaccine for the coronavirus. Slaoui faced criticism, particularly from Senator Elizabeth Warren
Elizabeth Ann Warren (née Herring; born June 22, 1949) is an American politician and former law professor who is the senior United States senator from Massachusetts, serving since 2013. A member of the Democratic Party and regarded as a p ...
, for continuing to have Moderna stock options worth over $10 million. On May 18, 2020, Slaoui resigned from the board of manufacturing firm Lonza, which Moderna had partnered with to develop a coronavirus vaccine. On May 19, after initially denying a conflict of interest, Slaoui divested his Moderna stock and donated the value it had gained from May 14 onwards to cancer research.
On May 20, ''The New York Times
''The New York Times'' (''the Times'', ''NYT'', or the Gray Lady) is a daily newspaper based in New York City with a worldwide readership reported in 2020 to comprise a declining 840,000 paid print subscribers, and a growing 6 million paid ...
'' reported that Slaoui had also resigned as an adviser to Brii Biosciences, a firm with sizeable Chinese investments, and would be resigning from Artizan Biosciences and Clazado. According to Michael Caputo
Michael Raymon Caputo (born March 24, 1962) is an American political strategist and lobbyist. In April 2020, Caputo was appointed as assistant secretary of public affairs in the Department of Health and Human Services in the Trump administration. ...
, Slaoui's decision to retain his GSK stock, even after being announced as OPWASP's chief adviser, was cleared by the Department of Health and Human Services
The United States Department of Health and Human Services (HHS) is a cabinet-level executive branch department of the U.S. federal government created to protect the health of all Americans and providing essential human services. Its motto is ...
.
Slaoui was scheduled to speak at the annual Biotechnology Innovation Organization (BIO) conference on June 9, 2020, but ultimately pulled out, citing his failure to brief Congress beforehand.
On October 9, 2020 the ''Wall Street Journal'' quoted Slaoui as saying that the COVID-19 vaccines would be accompanied by a tracking mechanism provided jointly by McKesson, Google and Oracle. The tracking is capable of monitoring vaccine series uptake, as well as side effects.
Slaoui resigned from OPWASP on January 12, 2021.
Sexual harassment allegations
On March 24, 2021, Slaoui was fired as chairman of the board of directors of Galvani Bioelectronics
Galvani Bioelectronics is a Stevenage, United Kingdom-based bioelectronics R&D company.
History
It was founded by Alphabet Inc. subsidiary Verily Life Sciences and British pharmaceutical company GlaxoSmithKline (GSK) in November 2016. The partn ...
, medical research firm owned mostly by GSK, over what the board of GSK called “substantiated” sexual harassment allegations. In a statement, GSK said they had received a letter a month before Slaoui’s dismissal “containing allegations of sexual harassment and inappropriate conduct towards an employee of GSK by Dr. Slaoui” that “occurred several years ago when he was an employee of GSK”.
Personal life
Slaoui is Muslim. He is fluent in Arabic, English, and French. He is a citizen of Morocco, Belgium, and the United States.
Slaoui has three sons and is married to Kristen Slaoui (née Belmonte), a 1992 graduate of Gettysburg College. Slaoui's younger sister died at a young age from pertussis
Whooping cough, also known as pertussis or the 100-day cough, is a highly contagious bacterial disease. Initial symptoms are usually similar to those of the common cold with a runny nose, fever, and mild cough, but these are followed by two o ...
. One of his two younger brothers, a pediatrician, Amine, died from pancreatic cancer
Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. A number of types of panc ...
. His other brother, Mohamed, is a specialist in gastroenterology
Gastroenterology (from the Greek gastḗr- “belly”, -énteron “intestine”, and -logía "study of") is the branch of medicine focused on the digestive system and its disorders. The digestive system consists of the gastrointestinal tract ...
and his older sister, Hadia, is a university professor of French literature
French literature () generally speaking, is literature written in the French language, particularly by citizens of France; it may also refer to literature written by people living in France who speak traditional languages of France other than Fr ...
in Morocco.[
]
Memberships
GSK-related
* 2006–2015: Global Research & Development of GSK PLC, chairman
* 2006–2017: GSK PLC, board member
* 2009–2017: Global Vaccines of GSK PLC, chairman
Voluntary positions
* 2009–2020: Qatar Foundation
Qatar Foundation for Education, Science and Community Development ( ar, مؤسسة قطر) is a state-led non-profit organization in Qatar, founded in 1995 by then-emir Hamad bin Khalifa Al Thani and his second wife Moza bint Nasser. Qatar Found ...
, advisory board member
* Hamad Bin Khalifa University
Hamad Bin Khalifa University, ( ar, جامعة حمد بن خليفة) is a public university located within Education City in Doha, the capital city of Qatar. Hamad Bin Khalifa University (HBKU), a member of Qatar Foundation for Education, Scien ...
, board member
* 2015-2017: International AIDS Vaccine Initiative
The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit, public-private partnership working to accelerate the development of vaccines to prevent HIV infection and AIDS. IAVI researches and develops vaccine candidates, conducts ...
, board member
* 2018: Human Vaccines Project, board member
* National Academies of Sciences, Engineering, and Medicine
The National Academies of Sciences, Engineering, and Medicine (also known as NASEM or the National Academies) are the collective scientific national academy of the United States. The name is used interchangeably in two senses: (1) as an umbrell ...
, Forum on Medical and Public Health Preparedness for Disasters and Emergencies, member
After GSK
* 2016–2021: Galvani Bioelectronics
Galvani Bioelectronics is a Stevenage, United Kingdom-based bioelectronics R&D company.
History
It was founded by Alphabet Inc. subsidiary Verily Life Sciences and British pharmaceutical company GlaxoSmithKline (GSK) in November 2016. The partn ...
, board member; chairman
* August 2017: Intellia Therapeutics
Intellia Therapeutics is a clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. To fully realize the transformative potential of CRISPR-based technologies, Inte ...
, board member for two weeks before resigning for undisclosed conflict of interests
* 2017: SutroVax, board member; chairman
* 2017: Divide & Conquer LLC, director
* 2018: Monopteros LLC, chairman
* 2020–2020: Lonza Group
Lonza Group is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name ...
, board member
* 2017–2020: Moderna
Moderna, Inc. ( ) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to pro ...
, board member
* Until 2020: Artizan Biotechnology, board member
* Until 2020: Brii Biosciences, scientific and strategic advisor
* Until 2020: Clasado Biosciences, chairman[
]
Trade-related
* Biotechnology Innovation Organization
The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry.
It was founded in 1993 as the Biotechnology Industry Organization, and changed its name to the Biotechnology ...
(BIO), Health & Regulatory Affairs Committee, member
* PhRMA Foundation, board member
Recognition
Gettysburg College
Gettysburg College is a private liberal arts college in Gettysburg, Pennsylvania. Founded in 1832, the campus is adjacent to the Gettysburg Battlefield. Gettysburg College has about 2,600 students, with roughly equal numbers of men and women ...
awarded Slaoui an honorary Doctor of Science
Doctor of Science ( la, links=no, Scientiae Doctor), usually abbreviated Sc.D., D.Sc., S.D., or D.S., is an academic research degree awarded in a number of countries throughout the world. In some countries, "Doctor of Science" is the degree used f ...
in May 2017. In 2012, Slaoui was named as one of the "25 most influential people in biopharma today" by ''FierceBiotech''. In 2016, '' Fortune'' ranked him among "The World's 50 Greatest Leaders". ''The Medicine Maker'' included Slaoui in its 2018 list of "World’s Top 100 Medicine Makers".
Slaoui was cited as one of the Top 100 most influential Africans by New African
''New African'' is an English-language monthly news magazine based in London. Published since 1966, it is read by many people across the African continent and the African diaspora. It claims to be the oldest pan-African monthly in English, as well ...
magazine in 2020.
Selected works and publications
Works
*
*
*
*
*
*
*
*
Publications
*
References
Further reading
*
External links
*
*
*
*
*
{{DEFAULTSORT:Slaoui, Moncef
1959 births
Living people
Moroccan Muslims
American Muslims
Belgian Muslims
20th-century American scientists
21st-century American scientists
20th-century Belgian scientists
21st-century Belgian scientists
20th-century Moroccan people
21st-century Moroccan people
American immunologists
Belgian immunologists
COVID-19 pandemic in the United States
GSK plc people
Moroccan emigrants to the United States
Moroccan scientists
People from Agadir
Trump administration personnel
Université libre de Bruxelles alumni